Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/2/16 → 11/2/22 |
Funding
- Quintiles, Inc. (Prot #RPC01-3102 // Prot #RPC01-3102)
- Celgene International II Sàrl (Prot #RPC01-3102 // Prot #RPC01-3102)
Prot #RPC01-3102: A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
- Hanauer, stephen B (PD/PI)
Project: Research project